Kronos Bio Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,784	2,583	2,023	1,100	164.2	86.48
Revenue Growth (YoY)	-39.88%	27.71%	83.86%	570.05%	89.87%	-
Cost of Revenue	1,136	1,038	993.36	519.1	103.59	63.61
Gross Profit	648.3	1,546	1,029	581.1	60.61	22.86
Selling, General & Admin	114.08	106.9	154.72	25.87	5.5	1.2
Other Operating Expenses	-16.75	-16.25	-1.85	-1.97	0.85	0.03
Operating Expenses	97.43	90.65	152.87	23.91	6.35	1.23
Operating Income	550.87	1,455	876.54	557.19	54.26	21.63
Interest Expense	-533.12	-257.64	-82.46	-20.09	-3.96	-3.65
Interest & Investment Income	1,707	1,462	38.08	27.11	4.77	3.94
Currency Exchange Gain (Loss)	113.41	56.56	3.95	6.97	-0.04	-
Other Non Operating Income (Expenses)	-313.12	-269.55	-276.91	-148.43	-	-
EBT Excluding Unusual Items	1,525	2,447	559.2	422.76	55.02	21.92
Gain (Loss) on Sale of Investments	-19.75	31.1	26.38	0.02	-	-
Legal Settlements	-	-	-	-	-0.26	-
Pretax Income	1,505	2,478	585.58	422.78	54.76	21.92
Income Tax Expense	116.31	196.04	-142.65	-1.77	0.61	-0.27
Earnings From Continuing Operations	1,389	2,282	728.23	424.55	54.16	22.19
Minority Interest in Earnings	-6.25	-5.29	-0.58	-	-	-
Net Income	1,382	2,276	727.65	424.55	54.16	22.19
Net Income to Common	1,382	2,276	727.65	424.55	54.16	22.19
Net Income Growth	-11.76%	212.85%	71.39%	683.93%	144.06%	-
Shares Outstanding (Basic)	494	494	494	494	494	-
Shares Outstanding (Diluted)	494	494	494	494	494	-
EPS (Basic)	2.80	4.61	1.47	0.86	0.11	-
EPS (Diluted)	2.80	4.61	1.47	0.86	0.11	-
EPS Growth	-11.75%	212.85%	71.39%	683.93%	-	-
Free Cash Flow	154.96	697.53	717.81	222.06	-66.72	-8
Free Cash Flow Per Share	0.31	1.41	1.45	0.45	-0.14	-
Gross Margin	36.34%	59.83%	50.89%	52.82%	36.91%	26.44%
Operating Margin	30.88%	56.33%	43.33%	50.64%	33.05%	25.01%
Profit Margin	77.49%	88.12%	35.97%	38.59%	32.98%	25.66%
Free Cash Flow Margin	8.69%	27.00%	35.49%	20.18%	-40.63%	-9.25%
EBITDA	532.96	1,489	893.38	559.88	54.53	23.28
EBITDA Margin	29.88%	57.64%	44.17%	50.89%	33.21%	26.92%
D&A For EBITDA	-17.92	34.04	16.85	2.69	0.27	1.65
EBIT	550.87	1,455	876.54	557.19	54.26	21.63
EBIT Margin	30.88%	56.33%	43.33%	50.64%	33.05%	25.01%
Effective Tax Rate	7.73%	7.91%	-	-	1.11%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.